Vaccine Manufacturing

Moderna to build $500m mRNA vaccine manufacturing facility in Africa

07-Oct-2021 By Rachel Arthur

Moderna will build a state-of-the-art mRNA facility in Africa, with the goal of producing up to 500 million vaccine doses a year.

BioNTech looks at mRNA vaccine manufacturing options in Rwanda and Senegal

29-Aug-2021 By Rachel Arthur

BioNTech is looking at establishing vaccine manufacturing capabilities in Rwanda and Senegal to support long-term vaccine supply in Africa.

Biovac to manufacture Pfizer COVID-19 doses in Africa

21-Jul-2021 By Rachel Arthur

South African biopharmaceutical company The Biovac Institute will manufacture and distribute Pfizer and BioNTech’s COVID-19 vaccine in Africa, with the three companies signing a letter of intent this week.

‘Innovative vaccines on a massive scale’: Sanofi to create $475m vaccine production site in Singapore

12-Apr-2021 By Rachel Arthur

Sanofi will build a digitally-enabled, carbon-neutral vaccine manufacturing center in Singapore: designed to respond quickly to future pandemic risks and able to produce up to four vaccines simultaneously.

AstraZeneca in deal with Germany’s IDT Biologika to boost vaccine manufacturing capability

11-Feb-2021 By Jane Byrne

AstraZeneca and IDT Biologika are exploring options to accelerate output of finished COVID-19 Vaccine AstraZeneca in the second quarter of 2021 in order to help support Europe’s immediate vaccination needs during the pandemic.